Market Value1,434,861,498
Total Holdings62
File Date2025-02-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
ACHL / Achilles Therapeutics plc - Depositary Receipt (Common Stock)
ANNX / Annexon, Inc.
PODD / Insulet Corporation
FATE / Fate Therapeutics, Inc.
SRRK / Scholar Rock Holding Corporation
PLRX / Pliant Therapeutics, Inc.
ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock)
IVVD / Invivyd, Inc.
BOLD / Boundless Bio, Inc.
BEAM / Beam Therapeutics Inc.
FOLD / Amicus Therapeutics, Inc.
BHVN / Biohaven Ltd.
ESTA / Establishment Labs Holdings Inc.
IDYA / IDEAYA Biosciences, Inc.
ATRA / Atara Biotherapeutics, Inc.
SLN / Silence Therapeutics plc - Depositary Receipt (Common Stock)
CLDX / Celldex Therapeutics, Inc.
KROS / Keros Therapeutics, Inc.
FDMT / 4D Molecular Therapeutics, Inc.
SLDB / Solid Biosciences Inc.
BSX / Boston Scientific Corporation
IMNM / Immunome, Inc.
NRIX / Nurix Therapeutics, Inc.
PEN / Penumbra, Inc.
LVTX / LAVA Therapeutics N.V.
XERS / Xeris Biopharma Holdings, Inc.
LIVN / LivaNova PLC
VTYX / Ventyx Biosciences, Inc.
ADCT / ADC Therapeutics SA
AKRO / Akero Therapeutics, Inc.
STOK / Stoke Therapeutics, Inc.
KRYS / Krystal Biotech, Inc.
NGNE / Neurogene Inc.
NUVB / Nuvation Bio Inc.
BNTX / BioNTech SE - Depositary Receipt (Common Stock)
KYMR / Kymera Therapeutics, Inc.
CBLL / CeriBell, Inc.
ETNB / 89bio, Inc.
STXS / Stereotaxis, Inc.
CYTK / Cytokinetics, Incorporated
PRME / Prime Medicine, Inc.
ACIU / AC Immune SA
ALVR / AlloVir, Inc.
SYK / Stryker Corporation
VERV / Verve Therapeutics, Inc.
ARDX / Ardelyx, Inc.
IMVT / Immunovant, Inc.
ATXS / Astria Therapeutics, Inc.
GRTSQ / Gritstone bio, Inc.
CTLT / Catalent, Inc.
AUGX / Augmedix, Inc.
CABA / Cabaletta Bio, Inc.
IGMS / IGM Biosciences, Inc.
RGNX / REGENXBIO Inc.
ORKA / Oruka Therapeutics, Inc.
RAPT / RAPT Therapeutics, Inc.
COGT / Cogent Biosciences, Inc.
ZYME / Zymeworks Inc.
ISRG / Intuitive Surgical, Inc.
ALLK / Allakos Inc.
HOOK / HOOKIPA Pharma Inc.
STTK / Shattuck Labs, Inc.
RPTX / Repare Therapeutics Inc.
ABSI / Absci Corporation
REPL / Replimune Group, Inc.
ALXO / ALX Oncology Holdings Inc.